PA
AROC icon

PharVision Advisers’s Archrock AROC Stock Holding History

PharVision Advisers’s Portfolio AROC Stock Details AROC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,614
Closed -$224K – 135
2025
Q4 		$224K Sell
8,614
-3,450
-29% -$85.8K 0.11% 462
2025
Q3 		$317K Buy
+12,064
New +$291K 0.18% 196
2025
Q2 		– Sell
-7,811
Closed -$205K – 275
2025
Q1 		$205K Buy
+7,811
New +$211K 0.28% 197

Other funds holding AROC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

PharVision Advisers's AROC Position: Q1 2026 in Review

PharVision Advisers sold out of Archrock (AROC) in Q1 2026, closing a stake of 8,614 shares — an estimated $224K sold.

PharVision Advisers first reported a position in AROC in Q1 2025 and held it in 3 quarters. The position peaked at $317K in Q3 2025. 431 funds tracked by Wall St. Rank hold AROC as of Q1 2026.

  • PharVision Advisers reported no remaining Archrock position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 8,614 Archrock shares in Q1 2026, an estimated $224K.
  • PharVision Advisers first reported a position in Archrock in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Archrock position peaked at $317K in Q3 2025.
  • 431 funds tracked by Wall St. Rank held Archrock as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.